Savant Capital LLC lowered its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 19.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,943 shares of the company's stock after selling 41,690 shares during the quarter. Savant Capital LLC's holdings in Procter & Gamble were worth $24,498,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently added to or reduced their stakes in the company. Triodos Investment Management BV lifted its position in Procter & Gamble by 7.3% during the third quarter. Triodos Investment Management BV now owns 255,095 shares of the company's stock valued at $39,195,000 after purchasing an additional 17,400 shares during the period. Vanguard Group Inc. lifted its position in Procter & Gamble by 0.6% during the third quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company's stock valued at $36,050,992,000 after purchasing an additional 1,419,322 shares during the period. Strengthening Families & Communities LLC lifted its position in Procter & Gamble by 820.6% during the third quarter. Strengthening Families & Communities LLC now owns 14,803 shares of the company's stock valued at $2,308,000 after purchasing an additional 13,195 shares during the period. Heritage Wealth Management Inc. lifted its position in Procter & Gamble by 32.7% during the third quarter. Heritage Wealth Management Inc. now owns 150,814 shares of the company's stock valued at $23,173,000 after purchasing an additional 37,198 shares during the period. Finally, Gradient Investments LLC increased its holdings in Procter & Gamble by 12.8% in the fourth quarter. Gradient Investments LLC now owns 253,089 shares of the company's stock valued at $36,270,000 after buying an additional 28,777 shares in the last quarter. Institutional investors own 65.77% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on PG. Morgan Stanley cut their price objective on shares of Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating for the company in a report on Wednesday, April 22nd. BNP Paribas Exane cut their price objective on shares of Procter & Gamble from $172.00 to $165.00 and set an "outperform" rating for the company in a report on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a $163.00 price objective on shares of Procter & Gamble in a report on Monday, April 27th. The Goldman Sachs Group cut their price objective on shares of Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a report on Wednesday, April 8th. Finally, Piper Sandler lifted their price objective on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Friday, April 24th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $161.06.
Read Our Latest Report on PG
Procter & Gamble Stock Down 1.0%
PG stock opened at $146.07 on Friday. The stock has a market capitalization of $340.14 billion, a P/E ratio of 21.36, a P/E/G ratio of 6.32 and a beta of 0.41. The firm has a 50-day simple moving average of $144.47 and a 200-day simple moving average of $147.92. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $170.99.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The company had revenue of $21.24 billion during the quarter, compared to analysts' expectations of $21.52 billion. During the same quarter in the prior year, the company earned $1.54 EPS. Procter & Gamble's revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 24th were paid a dividend of $1.0885 per share. The ex-dividend date of this dividend was Friday, April 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. Procter & Gamble's dividend payout ratio is currently 63.60%.
Trending Headlines about Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.